nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Ibuprofen—Melphalan—breast cancer	0.319	1	CrCrCtD
Atenolol—ABCB1—breast cancer	0.19	1	CbGaD
Atenolol—ABCB1—Toremifene—breast cancer	0.057	0.223	CbGbCtD
Atenolol—ABCB1—Lapatinib—breast cancer	0.0416	0.162	CbGbCtD
Atenolol—ABCB1—Vinorelbine—breast cancer	0.0231	0.0901	CbGbCtD
Atenolol—ABCB1—Tamoxifen—breast cancer	0.0208	0.0813	CbGbCtD
Atenolol—ABCB1—Mitoxantrone—breast cancer	0.0203	0.0793	CbGbCtD
Atenolol—ABCB1—Gemcitabine—breast cancer	0.0179	0.0701	CbGbCtD
Atenolol—ABCB1—Paclitaxel—breast cancer	0.0162	0.0633	CbGbCtD
Atenolol—ABCB1—Irinotecan—breast cancer	0.016	0.0624	CbGbCtD
Atenolol—ABCB1—Vinblastine—breast cancer	0.0142	0.0555	CbGbCtD
Atenolol—ABCB1—Docetaxel—breast cancer	0.0117	0.0458	CbGbCtD
Atenolol—ABCB1—Doxorubicin—breast cancer	0.00873	0.0341	CbGbCtD
Atenolol—ABCB1—Methotrexate—breast cancer	0.00846	0.033	CbGbCtD
Atenolol—Procarbazine—CYP1B1—breast cancer	0.00113	0.237	CrCbGaD
Atenolol—Chlorphenesin—CYP19A1—breast cancer	0.000315	0.066	CrCbGaD
Atenolol—Chlorphenesin—BCHE—breast cancer	0.000314	0.0659	CrCbGaD
Atenolol—Ibuprofen—BCL2—breast cancer	0.000276	0.0579	CrCbGaD
Atenolol—Ibuprofen—ABCC1—breast cancer	0.000251	0.0525	CrCbGaD
Atenolol—Ibuprofen—CXCL8—breast cancer	0.000222	0.0464	CrCbGaD
Atenolol—Betaxolol—CYP2D6—breast cancer	0.000174	0.0365	CrCbGaD
Atenolol—Bisoprolol—CYP2D6—breast cancer	0.000168	0.0352	CrCbGaD
Atenolol—Acebutolol—CYP2D6—breast cancer	0.000159	0.0333	CrCbGaD
Atenolol—Oxprenolol—CYP2D6—breast cancer	0.000158	0.0331	CrCbGaD
Atenolol—Chlorphenesin—CYP3A4—breast cancer	0.000148	0.031	CrCbGaD
Atenolol—Chlorphenesin—PTGS2—breast cancer	0.000145	0.0303	CrCbGaD
Atenolol—Alprenolol—CYP2D6—breast cancer	0.000144	0.0303	CrCbGaD
Atenolol—Bisoprolol—CYP3A4—breast cancer	0.000144	0.0302	CrCbGaD
Atenolol—Metoprolol—CYP2D6—breast cancer	0.000134	0.0282	CrCbGaD
Atenolol—Pindolol—CYP2D6—breast cancer	0.000124	0.026	CrCbGaD
Atenolol—Acebutolol—ABCB1—breast cancer	0.000114	0.0238	CrCbGaD
Atenolol—Ibuprofen—PTGS1—breast cancer	0.000113	0.0237	CrCbGaD
Atenolol—Metoprolol—ABCB1—breast cancer	9.59e-05	0.0201	CrCbGaD
Atenolol—Propranolol—CYP1A1—breast cancer	9.11e-05	0.0191	CrCbGaD
Atenolol—Dyspnoea—Paclitaxel—breast cancer	6.92e-05	0.000351	CcSEcCtD
Atenolol—Headache—Thiotepa—breast cancer	6.9e-05	0.000351	CcSEcCtD
Atenolol—Somnolence—Paclitaxel—breast cancer	6.9e-05	0.00035	CcSEcCtD
Atenolol—Palpitations—Capecitabine—breast cancer	6.89e-05	0.00035	CcSEcCtD
Atenolol—Chest pain—Docetaxel—breast cancer	6.86e-05	0.000348	CcSEcCtD
Atenolol—Loss of consciousness—Capecitabine—breast cancer	6.86e-05	0.000348	CcSEcCtD
Atenolol—Nausea—Vinorelbine—breast cancer	6.85e-05	0.000348	CcSEcCtD
Atenolol—Renal failure—Epirubicin—breast cancer	6.84e-05	0.000347	CcSEcCtD
Atenolol—Dyspepsia—Paclitaxel—breast cancer	6.83e-05	0.000347	CcSEcCtD
Atenolol—Asthenia—Irinotecan—breast cancer	6.82e-05	0.000347	CcSEcCtD
Atenolol—Asthenia—Mitoxantrone—breast cancer	6.82e-05	0.000347	CcSEcCtD
Atenolol—Cough—Capecitabine—breast cancer	6.81e-05	0.000346	CcSEcCtD
Atenolol—Propranolol—CYP2D6—breast cancer	6.78e-05	0.0142	CrCbGaD
Atenolol—Decreased appetite—Paclitaxel—breast cancer	6.74e-05	0.000343	CcSEcCtD
Atenolol—Dry mouth—Docetaxel—breast cancer	6.71e-05	0.000341	CcSEcCtD
Atenolol—Gastrointestinal disorder—Paclitaxel—breast cancer	6.7e-05	0.00034	CcSEcCtD
Atenolol—Fatigue—Paclitaxel—breast cancer	6.69e-05	0.00034	CcSEcCtD
Atenolol—Sweating—Epirubicin—breast cancer	6.67e-05	0.000339	CcSEcCtD
Atenolol—Asthenia—Gemcitabine—breast cancer	6.65e-05	0.000338	CcSEcCtD
Atenolol—Chest pain—Capecitabine—breast cancer	6.64e-05	0.000337	CcSEcCtD
Atenolol—Constipation—Paclitaxel—breast cancer	6.63e-05	0.000337	CcSEcCtD
Atenolol—Pain—Paclitaxel—breast cancer	6.63e-05	0.000337	CcSEcCtD
Atenolol—Confusional state—Docetaxel—breast cancer	6.63e-05	0.000337	CcSEcCtD
Atenolol—Anxiety—Capecitabine—breast cancer	6.62e-05	0.000336	CcSEcCtD
Atenolol—Oedema—Docetaxel—breast cancer	6.58e-05	0.000334	CcSEcCtD
Atenolol—Discomfort—Capecitabine—breast cancer	6.56e-05	0.000333	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—breast cancer	6.56e-05	0.000333	CcSEcCtD
Atenolol—Pruritus—Gemcitabine—breast cancer	6.56e-05	0.000333	CcSEcCtD
Atenolol—Nausea—Thiotepa—breast cancer	6.54e-05	0.000332	CcSEcCtD
Atenolol—Diarrhoea—Irinotecan—breast cancer	6.51e-05	0.000331	CcSEcCtD
Atenolol—Diarrhoea—Mitoxantrone—breast cancer	6.51e-05	0.000331	CcSEcCtD
Atenolol—Dry mouth—Capecitabine—breast cancer	6.5e-05	0.00033	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—breast cancer	6.49e-05	0.00033	CcSEcCtD
Atenolol—Shock—Docetaxel—breast cancer	6.47e-05	0.000329	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—breast cancer	6.46e-05	0.0135	CrCbGaD
Atenolol—Pruritus—Fluorouracil—breast cancer	6.45e-05	0.000327	CcSEcCtD
Atenolol—Thrombocytopenia—Docetaxel—breast cancer	6.44e-05	0.000327	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—breast cancer	6.43e-05	0.000327	CcSEcCtD
Atenolol—Visual impairment—Methotrexate—breast cancer	6.43e-05	0.000327	CcSEcCtD
Atenolol—Confusional state—Capecitabine—breast cancer	6.42e-05	0.000326	CcSEcCtD
Atenolol—Tachycardia—Docetaxel—breast cancer	6.42e-05	0.000326	CcSEcCtD
Atenolol—Feeling abnormal—Paclitaxel—breast cancer	6.39e-05	0.000325	CcSEcCtD
Atenolol—Oedema—Capecitabine—breast cancer	6.37e-05	0.000323	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—breast cancer	6.36e-05	0.000323	CcSEcCtD
Atenolol—Diarrhoea—Gemcitabine—breast cancer	6.34e-05	0.000322	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—breast cancer	6.33e-05	0.000321	CcSEcCtD
Atenolol—Dizziness—Irinotecan—breast cancer	6.29e-05	0.00032	CcSEcCtD
Atenolol—Anorexia—Docetaxel—breast cancer	6.27e-05	0.000318	CcSEcCtD
Atenolol—Shock—Capecitabine—breast cancer	6.26e-05	0.000318	CcSEcCtD
Atenolol—Diarrhoea—Fluorouracil—breast cancer	6.23e-05	0.000317	CcSEcCtD
Atenolol—Thrombocytopenia—Capecitabine—breast cancer	6.23e-05	0.000317	CcSEcCtD
Atenolol—Tinnitus—Methotrexate—breast cancer	6.22e-05	0.000316	CcSEcCtD
Atenolol—Tachycardia—Capecitabine—breast cancer	6.21e-05	0.000316	CcSEcCtD
Atenolol—Sweating—Doxorubicin—breast cancer	6.17e-05	0.000313	CcSEcCtD
Atenolol—Hyperhidrosis—Capecitabine—breast cancer	6.15e-05	0.000313	CcSEcCtD
Atenolol—Hypotension—Docetaxel—breast cancer	6.14e-05	0.000312	CcSEcCtD
Atenolol—Body temperature increased—Paclitaxel—breast cancer	6.13e-05	0.000312	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—breast cancer	6.07e-05	0.000308	CcSEcCtD
Atenolol—Anorexia—Capecitabine—breast cancer	6.07e-05	0.000308	CcSEcCtD
Atenolol—Dizziness—Fluorouracil—breast cancer	6.02e-05	0.000306	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—breast cancer	6.02e-05	0.000306	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—breast cancer	6e-05	0.000305	CcSEcCtD
Atenolol—Rash—Mitoxantrone—breast cancer	6e-05	0.000305	CcSEcCtD
Atenolol—Rash—Irinotecan—breast cancer	6e-05	0.000305	CcSEcCtD
Atenolol—Dermatitis—Irinotecan—breast cancer	5.99e-05	0.000304	CcSEcCtD
Atenolol—Dermatitis—Mitoxantrone—breast cancer	5.99e-05	0.000304	CcSEcCtD
Atenolol—Headache—Irinotecan—breast cancer	5.96e-05	0.000303	CcSEcCtD
Atenolol—Headache—Mitoxantrone—breast cancer	5.96e-05	0.000303	CcSEcCtD
Atenolol—Hypotension—Capecitabine—breast cancer	5.95e-05	0.000302	CcSEcCtD
Atenolol—Insomnia—Docetaxel—breast cancer	5.95e-05	0.000302	CcSEcCtD
Atenolol—Paraesthesia—Docetaxel—breast cancer	5.9e-05	0.0003	CcSEcCtD
Atenolol—Alopecia—Methotrexate—breast cancer	5.89e-05	0.000299	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—breast cancer	5.88e-05	0.000299	CcSEcCtD
Atenolol—Dyspnoea—Docetaxel—breast cancer	5.86e-05	0.000298	CcSEcCtD
Atenolol—Somnolence—Docetaxel—breast cancer	5.85e-05	0.000297	CcSEcCtD
Atenolol—Rash—Gemcitabine—breast cancer	5.84e-05	0.000297	CcSEcCtD
Atenolol—Dermatitis—Gemcitabine—breast cancer	5.84e-05	0.000296	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—breast cancer	5.82e-05	0.000296	CcSEcCtD
Atenolol—Propranolol—CYP3A4—breast cancer	5.82e-05	0.0122	CrCbGaD
Atenolol—Headache—Gemcitabine—breast cancer	5.8e-05	0.000295	CcSEcCtD
Atenolol—Flushing—Epirubicin—breast cancer	5.79e-05	0.000294	CcSEcCtD
Atenolol—Dyspepsia—Docetaxel—breast cancer	5.79e-05	0.000294	CcSEcCtD
Atenolol—Ibuprofen—ALB—breast cancer	5.76e-05	0.0121	CrCbGaD
Atenolol—Insomnia—Capecitabine—breast cancer	5.76e-05	0.000292	CcSEcCtD
Atenolol—Rash—Fluorouracil—breast cancer	5.74e-05	0.000292	CcSEcCtD
Atenolol—Dermatitis—Fluorouracil—breast cancer	5.74e-05	0.000292	CcSEcCtD
Atenolol—Paraesthesia—Capecitabine—breast cancer	5.72e-05	0.00029	CcSEcCtD
Atenolol—Decreased appetite—Docetaxel—breast cancer	5.72e-05	0.00029	CcSEcCtD
Atenolol—Headache—Fluorouracil—breast cancer	5.71e-05	0.00029	CcSEcCtD
Atenolol—Gastrointestinal disorder—Docetaxel—breast cancer	5.68e-05	0.000288	CcSEcCtD
Atenolol—Dyspnoea—Capecitabine—breast cancer	5.68e-05	0.000288	CcSEcCtD
Atenolol—Fatigue—Docetaxel—breast cancer	5.67e-05	0.000288	CcSEcCtD
Atenolol—Nausea—Mitoxantrone—breast cancer	5.65e-05	0.000287	CcSEcCtD
Atenolol—Nausea—Irinotecan—breast cancer	5.65e-05	0.000287	CcSEcCtD
Atenolol—Constipation—Docetaxel—breast cancer	5.62e-05	0.000286	CcSEcCtD
Atenolol—Pain—Docetaxel—breast cancer	5.62e-05	0.000286	CcSEcCtD
Atenolol—Dyspepsia—Capecitabine—breast cancer	5.6e-05	0.000285	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—breast cancer	5.58e-05	0.000283	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—breast cancer	5.57e-05	0.000283	CcSEcCtD
Atenolol—Asthenia—Paclitaxel—breast cancer	5.57e-05	0.000283	CcSEcCtD
Atenolol—Decreased appetite—Capecitabine—breast cancer	5.53e-05	0.000281	CcSEcCtD
Atenolol—Alopecia—Epirubicin—breast cancer	5.52e-05	0.00028	CcSEcCtD
Atenolol—Nausea—Gemcitabine—breast cancer	5.5e-05	0.00028	CcSEcCtD
Atenolol—Gastrointestinal disorder—Capecitabine—breast cancer	5.5e-05	0.000279	CcSEcCtD
Atenolol—Ibuprofen—ABCB1—breast cancer	5.5e-05	0.0115	CrCbGaD
Atenolol—Fatigue—Capecitabine—breast cancer	5.49e-05	0.000279	CcSEcCtD
Atenolol—Pruritus—Paclitaxel—breast cancer	5.49e-05	0.000279	CcSEcCtD
Atenolol—Vision blurred—Methotrexate—breast cancer	5.47e-05	0.000278	CcSEcCtD
Atenolol—Pain—Capecitabine—breast cancer	5.44e-05	0.000277	CcSEcCtD
Atenolol—Constipation—Capecitabine—breast cancer	5.44e-05	0.000277	CcSEcCtD
Atenolol—Feeling abnormal—Docetaxel—breast cancer	5.42e-05	0.000275	CcSEcCtD
Atenolol—Nausea—Fluorouracil—breast cancer	5.41e-05	0.000275	CcSEcCtD
Atenolol—Ill-defined disorder—Methotrexate—breast cancer	5.39e-05	0.000274	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—breast cancer	5.39e-05	0.000274	CcSEcCtD
Atenolol—Flushing—Doxorubicin—breast cancer	5.36e-05	0.000272	CcSEcCtD
Atenolol—Tension—Epirubicin—breast cancer	5.33e-05	0.000271	CcSEcCtD
Atenolol—Diarrhoea—Paclitaxel—breast cancer	5.31e-05	0.00027	CcSEcCtD
Atenolol—Nervousness—Epirubicin—breast cancer	5.28e-05	0.000268	CcSEcCtD
Atenolol—Feeling abnormal—Capecitabine—breast cancer	5.25e-05	0.000266	CcSEcCtD
Atenolol—Malaise—Methotrexate—breast cancer	5.24e-05	0.000266	CcSEcCtD
Atenolol—Vertigo—Methotrexate—breast cancer	5.22e-05	0.000265	CcSEcCtD
Atenolol—Body temperature increased—Docetaxel—breast cancer	5.2e-05	0.000264	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—breast cancer	5.16e-05	0.000262	CcSEcCtD
Atenolol—Dizziness—Paclitaxel—breast cancer	5.13e-05	0.000261	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—breast cancer	5.12e-05	0.00026	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—breast cancer	5.1e-05	0.000259	CcSEcCtD
Atenolol—Cough—Methotrexate—breast cancer	5.07e-05	0.000257	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—breast cancer	5.04e-05	0.000256	CcSEcCtD
Atenolol—Body temperature increased—Capecitabine—breast cancer	5.03e-05	0.000256	CcSEcCtD
Atenolol—Chest pain—Methotrexate—breast cancer	4.94e-05	0.000251	CcSEcCtD
Atenolol—Tension—Doxorubicin—breast cancer	4.93e-05	0.000251	CcSEcCtD
Atenolol—Malaise—Epirubicin—breast cancer	4.9e-05	0.000249	CcSEcCtD
Atenolol—Rash—Paclitaxel—breast cancer	4.89e-05	0.000248	CcSEcCtD
Atenolol—Dermatitis—Paclitaxel—breast cancer	4.89e-05	0.000248	CcSEcCtD
Atenolol—Discomfort—Methotrexate—breast cancer	4.88e-05	0.000248	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—breast cancer	4.88e-05	0.000248	CcSEcCtD
Atenolol—Vertigo—Epirubicin—breast cancer	4.88e-05	0.000248	CcSEcCtD
Atenolol—Syncope—Epirubicin—breast cancer	4.87e-05	0.000248	CcSEcCtD
Atenolol—Headache—Paclitaxel—breast cancer	4.86e-05	0.000247	CcSEcCtD
Atenolol—Propranolol—ABCB1—breast cancer	4.84e-05	0.0101	CrCbGaD
Atenolol—Palpitations—Epirubicin—breast cancer	4.8e-05	0.000244	CcSEcCtD
Atenolol—Confusional state—Methotrexate—breast cancer	4.78e-05	0.000243	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—breast cancer	4.78e-05	0.000243	CcSEcCtD
Atenolol—Cough—Epirubicin—breast cancer	4.74e-05	0.000241	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—breast cancer	4.74e-05	0.000241	CcSEcCtD
Atenolol—Asthenia—Docetaxel—breast cancer	4.72e-05	0.00024	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—breast cancer	4.67e-05	0.000237	CcSEcCtD
Atenolol—Pruritus—Docetaxel—breast cancer	4.65e-05	0.000236	CcSEcCtD
Atenolol—Thrombocytopenia—Methotrexate—breast cancer	4.64e-05	0.000236	CcSEcCtD
Atenolol—Chest pain—Epirubicin—breast cancer	4.63e-05	0.000235	CcSEcCtD
Atenolol—Anxiety—Epirubicin—breast cancer	4.61e-05	0.000234	CcSEcCtD
Atenolol—Nausea—Paclitaxel—breast cancer	4.61e-05	0.000234	CcSEcCtD
Atenolol—Hyperhidrosis—Methotrexate—breast cancer	4.58e-05	0.000233	CcSEcCtD
Atenolol—Discomfort—Epirubicin—breast cancer	4.57e-05	0.000232	CcSEcCtD
Atenolol—Asthenia—Capecitabine—breast cancer	4.57e-05	0.000232	CcSEcCtD
Atenolol—Malaise—Doxorubicin—breast cancer	4.53e-05	0.00023	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—breast cancer	4.52e-05	0.00023	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—breast cancer	4.52e-05	0.000229	CcSEcCtD
Atenolol—Anorexia—Methotrexate—breast cancer	4.52e-05	0.000229	CcSEcCtD
Atenolol—Syncope—Doxorubicin—breast cancer	4.51e-05	0.000229	CcSEcCtD
Atenolol—Pruritus—Capecitabine—breast cancer	4.5e-05	0.000229	CcSEcCtD
Atenolol—Diarrhoea—Docetaxel—breast cancer	4.5e-05	0.000229	CcSEcCtD
Atenolol—Confusional state—Epirubicin—breast cancer	4.47e-05	0.000227	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—breast cancer	4.44e-05	0.000226	CcSEcCtD
Atenolol—Oedema—Epirubicin—breast cancer	4.44e-05	0.000225	CcSEcCtD
Atenolol—Hypotension—Methotrexate—breast cancer	4.43e-05	0.000225	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—breast cancer	4.42e-05	0.000224	CcSEcCtD
Atenolol—Cough—Doxorubicin—breast cancer	4.39e-05	0.000223	CcSEcCtD
Atenolol—Shock—Epirubicin—breast cancer	4.36e-05	0.000222	CcSEcCtD
Atenolol—Diarrhoea—Capecitabine—breast cancer	4.36e-05	0.000221	CcSEcCtD
Atenolol—Dizziness—Docetaxel—breast cancer	4.35e-05	0.000221	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—breast cancer	4.34e-05	0.000221	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—breast cancer	4.33e-05	0.00022	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—breast cancer	4.29e-05	0.000218	CcSEcCtD
Atenolol—Insomnia—Methotrexate—breast cancer	4.29e-05	0.000218	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—breast cancer	4.28e-05	0.000217	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—breast cancer	4.27e-05	0.000217	CcSEcCtD
Atenolol—Paraesthesia—Methotrexate—breast cancer	4.26e-05	0.000216	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—breast cancer	4.23e-05	0.000215	CcSEcCtD
Atenolol—Anorexia—Epirubicin—breast cancer	4.23e-05	0.000215	CcSEcCtD
Atenolol—Dyspnoea—Methotrexate—breast cancer	4.23e-05	0.000215	CcSEcCtD
Atenolol—Somnolence—Methotrexate—breast cancer	4.21e-05	0.000214	CcSEcCtD
Atenolol—Dizziness—Capecitabine—breast cancer	4.21e-05	0.000214	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—breast cancer	4.19e-05	0.000213	CcSEcCtD
Atenolol—Dyspepsia—Methotrexate—breast cancer	4.17e-05	0.000212	CcSEcCtD
Atenolol—Rash—Docetaxel—breast cancer	4.15e-05	0.000211	CcSEcCtD
Atenolol—Hypotension—Epirubicin—breast cancer	4.14e-05	0.000211	CcSEcCtD
Atenolol—Dermatitis—Docetaxel—breast cancer	4.14e-05	0.00021	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—breast cancer	4.14e-05	0.00021	CcSEcCtD
Atenolol—Decreased appetite—Methotrexate—breast cancer	4.12e-05	0.000209	CcSEcCtD
Atenolol—Headache—Docetaxel—breast cancer	4.12e-05	0.000209	CcSEcCtD
Atenolol—Oedema—Doxorubicin—breast cancer	4.1e-05	0.000208	CcSEcCtD
Atenolol—Gastrointestinal disorder—Methotrexate—breast cancer	4.09e-05	0.000208	CcSEcCtD
Atenolol—Fatigue—Methotrexate—breast cancer	4.09e-05	0.000208	CcSEcCtD
Atenolol—Pain—Methotrexate—breast cancer	4.05e-05	0.000206	CcSEcCtD
Atenolol—Shock—Doxorubicin—breast cancer	4.04e-05	0.000205	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—breast cancer	4.02e-05	0.000204	CcSEcCtD
Atenolol—Rash—Capecitabine—breast cancer	4.01e-05	0.000204	CcSEcCtD
Atenolol—Insomnia—Epirubicin—breast cancer	4.01e-05	0.000204	CcSEcCtD
Atenolol—Dermatitis—Capecitabine—breast cancer	4.01e-05	0.000204	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—breast cancer	4.01e-05	0.000203	CcSEcCtD
Atenolol—Headache—Capecitabine—breast cancer	3.99e-05	0.000203	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—breast cancer	3.98e-05	0.000202	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—breast cancer	3.97e-05	0.000202	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—breast cancer	3.95e-05	0.000201	CcSEcCtD
Atenolol—Somnolence—Epirubicin—breast cancer	3.94e-05	0.0002	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—breast cancer	3.91e-05	0.000199	CcSEcCtD
Atenolol—Nausea—Docetaxel—breast cancer	3.91e-05	0.000198	CcSEcCtD
Atenolol—Feeling abnormal—Methotrexate—breast cancer	3.91e-05	0.000198	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—breast cancer	3.9e-05	0.000198	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—breast cancer	3.86e-05	0.000196	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—breast cancer	3.83e-05	0.000195	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—breast cancer	3.83e-05	0.000194	CcSEcCtD
Atenolol—Fatigue—Epirubicin—breast cancer	3.82e-05	0.000194	CcSEcCtD
Atenolol—Pain—Epirubicin—breast cancer	3.79e-05	0.000193	CcSEcCtD
Atenolol—Constipation—Epirubicin—breast cancer	3.79e-05	0.000193	CcSEcCtD
Atenolol—Nausea—Capecitabine—breast cancer	3.78e-05	0.000192	CcSEcCtD
Atenolol—Body temperature increased—Methotrexate—breast cancer	3.75e-05	0.00019	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—breast cancer	3.71e-05	0.000189	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—breast cancer	3.68e-05	0.000187	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—breast cancer	3.66e-05	0.000186	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—breast cancer	3.65e-05	0.000186	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—breast cancer	3.65e-05	0.000185	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—breast cancer	3.61e-05	0.000183	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—breast cancer	3.57e-05	0.000181	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—breast cancer	3.54e-05	0.00018	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—breast cancer	3.54e-05	0.00018	CcSEcCtD
Atenolol—Pain—Doxorubicin—breast cancer	3.51e-05	0.000178	CcSEcCtD
Atenolol—Constipation—Doxorubicin—breast cancer	3.51e-05	0.000178	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—breast cancer	3.51e-05	0.000178	CcSEcCtD
Atenolol—Asthenia—Methotrexate—breast cancer	3.4e-05	0.000173	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—breast cancer	3.38e-05	0.000172	CcSEcCtD
Atenolol—Pruritus—Methotrexate—breast cancer	3.35e-05	0.00017	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—breast cancer	3.24e-05	0.000165	CcSEcCtD
Atenolol—Diarrhoea—Methotrexate—breast cancer	3.24e-05	0.000165	CcSEcCtD
Atenolol—Asthenia—Epirubicin—breast cancer	3.18e-05	0.000162	CcSEcCtD
Atenolol—Pruritus—Epirubicin—breast cancer	3.14e-05	0.000159	CcSEcCtD
Atenolol—Dizziness—Methotrexate—breast cancer	3.13e-05	0.000159	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—breast cancer	3.03e-05	0.000154	CcSEcCtD
Atenolol—Rash—Methotrexate—breast cancer	2.99e-05	0.000152	CcSEcCtD
Atenolol—Dermatitis—Methotrexate—breast cancer	2.99e-05	0.000152	CcSEcCtD
Atenolol—Headache—Methotrexate—breast cancer	2.97e-05	0.000151	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—breast cancer	2.94e-05	0.00015	CcSEcCtD
Atenolol—Dizziness—Epirubicin—breast cancer	2.93e-05	0.000149	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—breast cancer	2.9e-05	0.000147	CcSEcCtD
Atenolol—Nausea—Methotrexate—breast cancer	2.82e-05	0.000143	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—breast cancer	2.81e-05	0.000143	CcSEcCtD
Atenolol—Rash—Epirubicin—breast cancer	2.8e-05	0.000142	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—breast cancer	2.79e-05	0.000142	CcSEcCtD
Atenolol—Headache—Epirubicin—breast cancer	2.78e-05	0.000141	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—breast cancer	2.71e-05	0.000138	CcSEcCtD
Atenolol—Nausea—Epirubicin—breast cancer	2.63e-05	0.000134	CcSEcCtD
Atenolol—Rash—Doxorubicin—breast cancer	2.59e-05	0.000131	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—breast cancer	2.59e-05	0.000131	CcSEcCtD
Atenolol—Headache—Doxorubicin—breast cancer	2.57e-05	0.000131	CcSEcCtD
Atenolol—Nausea—Doxorubicin—breast cancer	2.44e-05	0.000124	CcSEcCtD
Atenolol—ADRB2—Signaling Pathways—TCF7L2—breast cancer	1.02e-05	0.000307	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.02e-05	0.000305	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.01e-05	0.000303	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	1.01e-05	0.000302	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH2—breast cancer	1.01e-05	0.000302	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	1e-05	0.0003	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	9.86e-06	0.000296	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH2—breast cancer	9.86e-06	0.000296	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AGTR1—breast cancer	9.8e-06	0.000294	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PRL—breast cancer	9.8e-06	0.000294	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	9.78e-06	0.000293	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STK11—breast cancer	9.66e-06	0.00029	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ADAM10—breast cancer	9.66e-06	0.00029	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PRL—breast cancer	9.59e-06	0.000288	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AGTR1—breast cancer	9.59e-06	0.000288	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLG—breast cancer	9.55e-06	0.000287	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	9.52e-06	0.000286	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STK11—breast cancer	9.45e-06	0.000284	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ADAM10—breast cancer	9.45e-06	0.000284	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT2—breast cancer	9.45e-06	0.000283	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF10—breast cancer	9.4e-06	0.000282	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLG—breast cancer	9.34e-06	0.00028	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT2—breast cancer	9.24e-06	0.000277	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	9.21e-06	0.000276	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF10—breast cancer	9.19e-06	0.000276	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	9.08e-06	0.000272	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PDGFA—breast cancer	9.07e-06	0.000272	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—DPYD—breast cancer	9.07e-06	0.000272	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MED12—breast cancer	9.07e-06	0.000272	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	8.94e-06	0.000268	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALDOA—breast cancer	8.93e-06	0.000268	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	8.88e-06	0.000266	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PDGFA—breast cancer	8.87e-06	0.000266	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ITPR1—breast cancer	8.8e-06	0.000264	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	8.74e-06	0.000262	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP3—breast cancer	8.74e-06	0.000262	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB4—breast cancer	8.74e-06	0.000262	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT5A—breast cancer	8.74e-06	0.000262	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	8.71e-06	0.000261	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA3—breast cancer	8.66e-06	0.00026	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ITPR1—breast cancer	8.6e-06	0.000258	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A2—breast cancer	8.6e-06	0.000258	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT5A—breast cancer	8.55e-06	0.000256	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB4—breast cancer	8.55e-06	0.000256	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP3—breast cancer	8.55e-06	0.000256	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	8.52e-06	0.000256	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SMAD4—breast cancer	8.46e-06	0.000254	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CPT1A—breast cancer	8.43e-06	0.000253	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ABCG2—breast cancer	8.43e-06	0.000253	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTR—breast cancer	8.43e-06	0.000253	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1R—breast cancer	8.41e-06	0.000252	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	8.37e-06	0.000251	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SMAD4—breast cancer	8.28e-06	0.000248	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HPGDS—breast cancer	8.27e-06	0.000248	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HES1—breast cancer	8.26e-06	0.000248	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1R—breast cancer	8.23e-06	0.000247	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HBA1—breast cancer	8.21e-06	0.000246	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NCOR1—breast cancer	8.21e-06	0.000246	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	8.21e-06	0.000246	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	8.19e-06	0.000246	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGF1—breast cancer	8.12e-06	0.000244	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CSF2—breast cancer	8.12e-06	0.000244	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—RAF1—breast cancer	8.1e-06	0.000243	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HES1—breast cancer	8.08e-06	0.000242	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NRG1—breast cancer	8.06e-06	0.000242	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NCOR1—breast cancer	8.04e-06	0.000241	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	8.04e-06	0.000241	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTT1—breast cancer	8.02e-06	0.000241	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ACHE—breast cancer	8.02e-06	0.000241	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—H2AFX—breast cancer	8e-06	0.00024	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IL2—breast cancer	8e-06	0.00024	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—E2F1—breast cancer	7.95e-06	0.000238	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CSF2—breast cancer	7.95e-06	0.000238	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGF1—breast cancer	7.95e-06	0.000238	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—RAF1—breast cancer	7.93e-06	0.000238	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	7.91e-06	0.000237	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NRG1—breast cancer	7.89e-06	0.000237	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—H2AFX—breast cancer	7.83e-06	0.000235	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IL2—breast cancer	7.83e-06	0.000235	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.78e-06	0.000233	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—E2F1—breast cancer	7.78e-06	0.000233	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	7.74e-06	0.000232	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SPP1—breast cancer	7.64e-06	0.000229	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	7.6e-06	0.000228	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP17A1—breast cancer	7.59e-06	0.000228	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB3—breast cancer	7.55e-06	0.000227	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGFR2—breast cancer	7.54e-06	0.000226	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ENO1—breast cancer	7.51e-06	0.000225	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS1—breast cancer	7.51e-06	0.000225	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SPP1—breast cancer	7.47e-06	0.000224	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	7.44e-06	0.000223	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB3—breast cancer	7.39e-06	0.000222	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGFR2—breast cancer	7.38e-06	0.000221	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP2D6—breast cancer	7.37e-06	0.000221	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL2—breast cancer	7.27e-06	0.000218	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TERT—breast cancer	7.24e-06	0.000217	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA2—breast cancer	7.23e-06	0.000217	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL2—breast cancer	7.11e-06	0.000213	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TERT—breast cancer	7.08e-06	0.000212	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	7.03e-06	0.000211	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	7.03e-06	0.000211	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—FASN—breast cancer	7.01e-06	0.00021	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—BCHE—breast cancer	6.98e-06	0.00021	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	6.92e-06	0.000208	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC5A5—breast cancer	6.9e-06	0.000207	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	6.88e-06	0.000206	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	6.77e-06	0.000203	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LEP—breast cancer	6.76e-06	0.000203	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CAV1—breast cancer	6.7e-06	0.000201	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SLC2A1—breast cancer	6.66e-06	0.0002	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NQO1—breast cancer	6.66e-06	0.0002	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KDR—breast cancer	6.62e-06	0.000199	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LEP—breast cancer	6.61e-06	0.000198	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CAV1—breast cancer	6.55e-06	0.000197	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP3A4—breast cancer	6.5e-06	0.000195	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KDR—breast cancer	6.48e-06	0.000194	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ESR1—breast cancer	6.45e-06	0.000194	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1B1—breast cancer	6.39e-06	0.000192	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—FN1—breast cancer	6.37e-06	0.000191	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	6.35e-06	0.000191	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ESR1—breast cancer	6.31e-06	0.000189	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	6.3e-06	0.000189	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HSP90AA1—breast cancer	6.26e-06	0.000188	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	6.24e-06	0.000187	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—FN1—breast cancer	6.23e-06	0.000187	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	6.16e-06	0.000185	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	6.1e-06	0.000183	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	6.1e-06	0.000183	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KIT—breast cancer	6.1e-06	0.000183	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APC—breast cancer	6.1e-06	0.000183	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOA1—breast cancer	6.09e-06	0.000183	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGF—breast cancer	6.03e-06	0.000181	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—STK11—breast cancer	6.01e-06	0.00018	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP19A1—breast cancer	6.01e-06	0.00018	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KIT—breast cancer	5.97e-06	0.000179	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	5.97e-06	0.000179	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APC—breast cancer	5.97e-06	0.000179	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGF—breast cancer	5.9e-06	0.000177	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	5.84e-06	0.000175	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—BRAF—breast cancer	5.73e-06	0.000172	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	5.71e-06	0.000171	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—BRAF—breast cancer	5.61e-06	0.000168	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IGF1—breast cancer	5.58e-06	0.000168	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—COMT—breast cancer	5.58e-06	0.000168	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT2—breast cancer	5.58e-06	0.000167	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTP1—breast cancer	5.56e-06	0.000167	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	5.56e-06	0.000167	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—HMOX1—breast cancer	5.48e-06	0.000164	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ITPR1—breast cancer	5.47e-06	0.000164	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IGF1—breast cancer	5.46e-06	0.000164	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT2—breast cancer	5.46e-06	0.000164	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	5.44e-06	0.000163	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	5.36e-06	0.000161	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	5.31e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	5.3e-06	0.000159	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	5.25e-06	0.000158	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	5.25e-06	0.000157	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	5.2e-06	0.000156	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	5.19e-06	0.000156	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—TYMS—breast cancer	5.17e-06	0.000155	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	5.14e-06	0.000154	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PLA2G4A—breast cancer	5.11e-06	0.000153	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GSTM1—breast cancer	5.11e-06	0.000153	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NCOR1—breast cancer	5.11e-06	0.000153	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—NOS3—breast cancer	5.06e-06	0.000152	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—NOS3—breast cancer	4.95e-06	0.000149	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GPX1—breast cancer	4.89e-06	0.000147	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP1A1—breast cancer	4.84e-06	0.000145	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	4.82e-06	0.000145	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MDM2—breast cancer	4.8e-06	0.000144	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ERCC2—breast cancer	4.8e-06	0.000144	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RAF1—breast cancer	4.79e-06	0.000144	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RELA—breast cancer	4.77e-06	0.000143	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	4.74e-06	0.000142	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	4.72e-06	0.000142	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MDM2—breast cancer	4.7e-06	0.000141	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RAF1—breast cancer	4.68e-06	0.000141	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	4.67e-06	0.00014	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MTOR—breast cancer	4.67e-06	0.00014	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RELA—breast cancer	4.66e-06	0.00014	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	4.63e-06	0.000139	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MTOR—breast cancer	4.57e-06	0.000137	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	4.57e-06	0.000137	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—MTHFR—breast cancer	4.51e-06	0.000135	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	4.49e-06	0.000135	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	4.46e-06	0.000134	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	4.39e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	4.39e-06	0.000132	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	4.36e-06	0.000131	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	4.34e-06	0.00013	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CASP3—breast cancer	4.3e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2—breast cancer	4.29e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	4.29e-06	0.000129	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—breast cancer	4.27e-06	0.000128	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	4.24e-06	0.000127	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CASP3—breast cancer	4.2e-06	0.000126	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2—breast cancer	4.2e-06	0.000126	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCND1—breast cancer	4.18e-06	0.000126	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—breast cancer	4.18e-06	0.000125	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—JUN—breast cancer	4.18e-06	0.000125	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CAV1—breast cancer	4.16e-06	0.000125	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	4.14e-06	0.000124	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCND1—breast cancer	4.09e-06	0.000123	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—JUN—breast cancer	4.08e-06	0.000123	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—breast cancer	4.06e-06	0.000122	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	4.05e-06	0.000122	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	4.05e-06	0.000121	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTEN—breast cancer	4.04e-06	0.000121	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—breast cancer	3.97e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	3.96e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	3.95e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTEN—breast cancer	3.95e-06	0.000119	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	3.94e-06	0.000118	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	3.86e-06	0.000116	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	3.85e-06	0.000116	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CG—breast cancer	3.79e-06	0.000114	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SRC—breast cancer	3.75e-06	0.000112	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SRC—breast cancer	3.66e-06	0.00011	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	3.65e-06	0.000109	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—breast cancer	3.61e-06	0.000108	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	3.57e-06	0.000107	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—breast cancer	3.53e-06	0.000106	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	3.45e-06	0.000104	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	3.38e-06	0.000101	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MYC—breast cancer	3.36e-06	0.000101	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	3.35e-06	0.0001	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CD—breast cancer	3.33e-06	0.0001	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALB—breast cancer	3.29e-06	9.87e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MYC—breast cancer	3.28e-06	9.85e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—EGFR—breast cancer	3.28e-06	9.85e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	3.28e-06	9.83e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—EGFR—breast cancer	3.21e-06	9.64e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—NOS3—breast cancer	3.15e-06	9.45e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—KRAS—breast cancer	3.1e-06	9.3e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—KRAS—breast cancer	3.03e-06	9.1e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CB—breast cancer	2.91e-06	8.72e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTGS2—breast cancer	2.88e-06	8.64e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	2.85e-06	8.55e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	2.79e-06	8.36e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TP53—breast cancer	2.76e-06	8.27e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TP53—breast cancer	2.7e-06	8.09e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—HRAS—breast cancer	2.64e-06	7.91e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—HRAS—breast cancer	2.58e-06	7.74e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—breast cancer	2.52e-06	7.57e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PTEN—breast cancer	2.51e-06	7.53e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—breast cancer	2.47e-06	7.4e-05	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—AKT1—breast cancer	2.33e-06	6.98e-05	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—AKT1—breast cancer	2.28e-06	6.83e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—PIK3CA—breast cancer	1.77e-06	5.31e-05	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—AKT1—breast cancer	1.45e-06	4.34e-05	CbGpPWpGaD
